Search results for "coma"

showing 10 items of 1084 documents

E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial.

2008

Purpose: To test the expanded polytetrafluoroethylene (ePTFE) as a new adjuvant in trabeculectomy. Methods: Consecutive glaucoma surgical inpatients were observed at the Department of Ophthalmology of Palermo University. Sixty patients (60 eyes) were randomly assigned to undergo trabeculectomy (T), trabeculectomy with mitomycin-C (TMMC), with ePTFE (TG) or with mitomycin-C and ePTFE (TGMMC). Postoperative visits were scheduled at 24 hr, 7 days, 1, 3, 6, 12, 18 and 24 months. Complete success and qualified success were assessed at two target intraocular pressure (IOP) levels – £21 and £17 mmHg – by Kaplan–Meier curves. Results: The postoperative IOP reduction was significant (P < 0.01) at th…

MaleIntraocular pressuremedicine.medical_specialtygenetic structuresmedicine.medical_treatmentMitomycinGlaucomaOcular HypotensionTrabeculectomyKaplan-Meier Estimatelaw.inventionRandomized controlled triallawpenetrating glaucoma surgerymedicineGlaucoma surgeryTrabeculectomyHumansPostoperative PeriodSurvival ratePolytetrafluoroethyleneIntraocular PressureE-PTFE (Gore-Tex)implantAgedDose-Response Relationship Drugbusiness.industryMitomycin CGlaucomaGeneral MedicineProstheses and ImplantsMiddle Agedmedicine.diseaserandomized clinical trialSurgerylow-dosage mitomycin-Cpenetrating glaucoma surgery; E-PTFE (Gore-Tex)implant; low-dosage mitomycin-C; randomized clinical trialOphthalmologyChemotherapy AdjuvantAnesthesiaFemaleImplantbusiness
researchProduct

Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial

2011

AIM: To verify the safety and efficacy of Ologen (OLO) implant as adjuvant compared with low-dosage mitomycin-C (MMC) in trabeculectomy. METHODS: This was a prospective randomized clinical trial with a 24-month follow-up. Forty glaucoma patients (40 eyes) were assigned to trabeculectomy with MMC or OLO. Primary outcome includes target IOP at ≤21, ≤17, and ≤15 mm Hg; complete (target IOP without medications), and qualified success (target IOP regardless of medications). Secondary outcomes include bleb evaluation, according to Moorfields Bleb Grading System (MBGS); spectral domain optical coherence tomography (SD-OCT) examination; number of glaucoma medications; and frequency of postoperative…

MaleIntraocular pressuremedicine.medical_specialtymedicine.medical_treatmentMitomycinGlaucomaTrabeculectomyMatrix (biology)law.inventionRandomized controlled triallawAbsorbable ImplantsmedicineTrabeculectomyHumansProspective StudiesIntraocular PressureAgedGlycosaminoglycansIntraoperative CareSettore MED/30 - Malattie Apparato Visivobusiness.industryMitomycin CGlaucomaProstheses and ImplantsMiddle AgedOlogen MMC trabeculectomymedicine.diseaseSurgeryOphthalmologyCross-Linking ReagentsClinical StudyFemaleImplantCollagenbusinessAdjuvantTomography Optical Coherence
researchProduct

Smoking and FOS expression from blood leukocyte transcripts in patients with coronary artery disease.

2011

International audience; OBJECTIVE: Analysis of the leukocyte transriptome, in particular the Finkel-Biskis-Jinkins Osteosarcoma (c-Fos) gene, which has a prominent role in inflammation, provides new insights into atherosclerosis mechanisms. Although smoking is a major risk factor, the links between smoking status and coronary artery disease (CAD) remains unclear. We aimed to analyze the relationship between smoking status and c-Fos expression in circulating leukocytes of patients with CAD. METHODS: c-Fos expression was measured by RT-Q-PCR, from blood leukocytes of 239 consecutive patients after acute myocardial infarction (MI). The patients were asked about their smoking status and stratif…

MaleMESH : RNA MessengerMESH: Chi-Square DistributionMESH : LeukocytesMESH : Prospective StudiesMESH : AgedMyocardial InfarctionSmoking PreventionMESH: Risk Assessmentc-FosMESH : Coronary Angiography0302 clinical medicineMESH : Genetic MarkersProspective StudiesMESH: Coronary Artery DiseaseAged 80 and over0303 health sciencesMESH: Middle AgedGenes fosMESH: Smoking Cessation3. Good healthMESH : SmokingMESH: Myocardial InfarctionOsteosarcomaSmoking statusCardiology and Cardiovascular MedicineGenetic Markersmedicine.medical_specialtyRisk AssessmentMESH: Leukocytes03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemHumansMESH : Middle AgedRNA MessengerMESH : Coronary Artery DiseaseRisk factorMESH : Aged 80 and overAgedChi-Square DistributionMESH: HumansMESH : Chi-Square DistributionMESH : Smoking CessationMESH : Humansmedicine.diseaseMESH: Coronary AngiographyLinear ModelsMESH: FemaleBlood leukocyte transcriptomeMESH : Genes fos030204 cardiovascular system & hematologyMESH: Genetic MarkersBioinformaticsCoronary AngiographyCoronary artery diseaseMESH: Linear ModelsCoronary artery diseaseMESH: Aged 80 and overRisk FactorsMESH: Risk FactorsMESH : Linear ModelsLeukocytesMESH : FemaleMESH : Risk AssessmentMESH: Agedc-FosbiologySmoking[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemMiddle AgedMESH : Risk Factors[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemCardiologyFemaleFrancemedicine.symptomInflammation MediatorsMESH: SmokingMESH : MaleMESH: Inflammation MediatorsInflammationMESH: Genes fosMESH: Multivariate AnalysisMESH : Inflammation MediatorsInternal medicinemedicineIn patientMESH : France030304 developmental biologyMESH: RNA Messengerbusiness.industryMESH : Multivariate AnalysisMESH: MaleMESH: Prospective StudiesMESH: FranceMultivariate Analysisbiology.proteinSmoking CessationMESH : Myocardial Infarctionbusiness
researchProduct

Chryseobacterium indologenes bacteraemia in a diabetic child

2005

Chryseobacterium indologenes is a non-fermentative Gram-negative bacillus that is a rare pathogen in humans. Its occurrence in diabetic children has not been previously reported. In this report, a case is described of C. indologenes bacteraemia possibly associated with the use of a peripheral venous catheter. A 2-year-old boy with type I diabetes mellitus was admitted due to a coma caused by cerebral oedema and was successfully treated for his neurological condition but presented on the tenth day after admission with fever of 40 degrees C, agitation, restlessness, lack of appetite, somnolence and fatigue. His pulse rate was 90 min(-1) and his respiratory rate was 20 min(-1). Laboratory stud…

MaleMicrobiology (medical)medicine.medical_specialtyChryseobacterium indologenesmedicine.medical_treatmentBacteremiaMicrobiologyFlavobacteriaceae InfectionsInternal medicineWhite blood cellDiabetes mellitusCatheterization PeripheralmedicineHumansMICROBIOLOGICAL CHARACTERISTICSChryseobacteriumComabusiness.industryCeftriaxoneMICROBIOLOGICAL CHARACTERISTICS; MENINGOSEPTICUM; INFECTIONSMENINGOSEPTICUMGeneral Medicinemedicine.diseaseAnti-Bacterial AgentsSurgeryDiabetes Mellitus Type 1medicine.anatomical_structureINFECTIONSChild PreschoolBacteremiaCeftriaxonePeripheral venous cathetermedicine.symptombusinessCentral venous cathetermedicine.drug
researchProduct

Nicotinamide exerts different acute effects on microcirculatory function and tissue oxygenation in rat tumors

1993

Abstract Purpose : Nicotinamide has been reported to preferentially radiosensitize tumor tissue, supposedly through a reduction in tumor hypoxia. This may occur as a result of nicotinamide-induced changes in tumor blood flow and therefore the present study was undertaken to evaluate the effect of nicotinamide on circulatory parameters in skeletal muscle and tumor tissue (subcutaneously-implanted DS-sarcomas) of the rat. Methods and Materials : Mean arterial blood pressure (measured in the common carotid artery using a pressure transducer) and red blood cell flux (as measured by laser Doppler flowmetry) were continuously monitored for 120 min following a single intraperitoneal application of…

MaleNiacinamideRadiation-Sensitizing AgentsCancer Researchmedicine.medical_specialtyBlood PressureMicrocirculationRats Sprague-Dawleychemistry.chemical_compoundOxygen ConsumptionInternal medicineAnimalsMedicineRadiology Nuclear Medicine and imagingRadiationNicotinamideTumor hypoxiabusiness.industryMicrocirculationMusclesBlood flowLaser Doppler velocimetryRatsB vitaminsEndocrinologyBlood pressureOncologychemistryCirculatory systemFemaleSarcoma ExperimentalbusinessNeoplasm TransplantationInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

No improvement in perfusion and oxygenation of experimental tumors upon application of vasodilator drugs

2001

The oxygen deficiency seen in solid tumors is predominantly caused by an insufficient O2 supply as a result of inadequate tumor perfusion. The aim of this study was to analyze whether a number of vasodilator drugs might be suitable to increase tumor perfusion and consequently improve the oxygenation status of experimental tumors. Rats with s.c. DS-sarcomas were treated with either Na+-nitroprusside (7-25 microg x min(-1) x kg(-1) BW) or nifedipine (10 microg x min(-1) x kg(-1) BW). Red blood cell (RBC) flux was assessed continuously using laser-Doppler flowmetry and mean tumor pO2 was measured polarographically using O2-sensitive catheter electrodes. Systemic application of the vasodilator …

MaleNitroprussideCancer Researchmedicine.medical_specialtyNifedipineVasodilator AgentsRats Sprague-DawleyNifedipineInternal medicineLaser-Doppler FlowmetrymedicineAnimalsInfusions IntravenousOncogenebusiness.industryOxygenationLaser Doppler velocimetryRatsOxygenRed blood cellmedicine.anatomical_structureEndocrinologyOncologyRegional Blood FlowCardiologyVascular resistanceSarcoma ExperimentalSodium nitroprussidebusinessPerfusionmedicine.drugInternational Journal of Oncology
researchProduct

Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study

2021

Background: Renal cell carcinoma with sarcomatoid differentiation is a highly aggressive form of kidney cancer. Objective: We aimed to analyze the outcomes of patients treated with cabozantinib for metastatic renal cell carcinoma with sarcomatoid features. Methods: We retrospectively collected data from 16 worldwide centers. Overall survival and progression-free survival were analyzed using Kaplan–Meier curves. Cox proportional models were used for univariate and multivariate analyses. Results: We collected data from 66 patients with metastatic sarcomatoid renal cell carcinoma receiving cabozantinib as second-line (51%) or third-line (49%) therapy. The median progression-free survival from …

MaleOncologyCancer Researchmedicine.medical_specialtyMultivariate analysisCabozantinibPyridineschemistry.chemical_compoundRenal cell carcinomaInternal medicinemedicineHumansAnilidesPharmacology (medical)Carcinoma Renal CellSarcomatoid DifferentiationRetrospective Studiesbusiness.industryHazard ratioCell Differentiationmedicine.diseaseKidney NeoplasmsConfidence intervalOncologychemistryMale patientFemalebusinessKidney cancerTargeted Oncology
researchProduct

One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients

2019

Purpose: Chemotherapy-induced nausea and vomiting (CINV) is one of the most feared and disturbing adverse events of cancer treatment associated with decreased adherence to effective chemotherapy regimens. For high-risk soft tissue sarcoma patients, receiving multiple-day chemotherapy (MD-CT), antiemetic guidelines recommend a combination of an NK 1 receptor antagonist (NK 1 -RA), a 5-HT 3 receptor antagonist (5HT 3 -RA), and dexamethasone on each day of the antineoplastic treatment. NEPA is the first oral fixed-dose combination of a highly selective NK 1 -RA, netupitant, and second-generation 5HT 3 -RA, palonosetron. So far, no data has been published in literature about the efficacy of a s…

MaleOncologyQuinuclidinesMultiple-dayPyridinesmedicine.medical_treatmentCINVPilot ProjectsDexamethasonechemistry.chemical_compound0302 clinical medicineNeurokinin-1 Receptor AntagonistsClinical endpointSerotonin 5-HT3 Receptor AntagonistsProspective Studies030212 general & internal medicineAged 80 and overSoft tissue sarcomaPalonosetronNauseaSarcomaMiddle AgedReceptors Neurokinin-1PalonosetronOncology030220 oncology & carcinogenesisVomitingFemaleOriginal Articlemedicine.symptommedicine.drugAdultmedicine.medical_specialtyVomitingmedicine.drug_classNauseaAntineoplastic Agents03 medical and health sciencesInternal medicinemedicineHumansAntiemeticNetupitantAuthor CorrectionAgedChemotherapybusiness.industryIsoquinolinesmedicine.diseasechemistryNetupitantAntiemeticsbusinessSupportive Care in Cancer
researchProduct

Prognostic relevance of CCN3 in Ewing sarcoma

2009

Ewing sarcoma is a highly aggressive malignant bone tumor occurring preferentially in children and young adults. At present, only clinical features, such as patient age, presence of clinically evident metastases at diagnosis, and poor response to neoadjuvant chemotherapy, are widely accepted as prognostic indicators in Ewing sarcoma. In this study, we assessed the prognostic value of CCN3 (Nov), a matricellular protein that play crucial roles in bone formation. Polyclonal antibodies directed against each of the different CCN3 modules were used to identify variant CCN3 proteins in tumors and to draw potential relationships between the expression of these variants and the outcome of patients …

MaleOncologymedicine.medical_specialtyPathologyAdolescentTumor suppressor genemedicine.medical_treatmentBlotting WesternGene ExpressionBone NeoplasmsKaplan-Meier EstimateSarcoma EwingPathology and Forensic MedicineNephroblastoma Overexpressed ProteinVon Willebrand factorInternal medicineBiomarkers TumormedicineHumansChildOligonucleotide Array Sequence AnalysisChemotherapyintegumentary systembiologybusiness.industryMatricellular proteinCancerAnatomical pathologyPrognosismedicine.diseaseImmunohistochemistryRadiation therapybiology.proteinFemaleSarcomabusinessHuman Pathology
researchProduct

Is the injection of tramadol effective at control of pain after impacted mandibular third molar extractions? A systematic review and meta-analysis.

2022

Third molar extraction is among the most common surgical procedures performed by oral-maxillofacial surgeons. Postoperative pain, swelling and trismus are common, especially in wisdom teeth, due to trauma to local tissues and the duration of the surgical procedure, among other factors. This systematic review was conducted in accordance with the ?Preferred Reporting Items for Systematic Reviews and Meta-Analyses? in order to answer the focused question: ?Is the local submucosal injection of tramadol effective at the control of postoperative pain in patients submitted to impacted mandibular third molar extractions??. We analyzed papers published until March 30, 2021 in the MEDLINE|PubMed, Web…

MalePain PostoperativeAnalgesicsTooth Impactedhead and neckpediatricOtorhinolaryngologyhistologicimmunohistochemistryTooth ExtractionHumansEdemaSurgeryFemaleMolar ThirdTrismusrhabdomyosarcomaGeneral DentistryUNESCO:CIENCIAS MÉDICASTramadolMedicina oral, patologia oral y cirugia bucal
researchProduct